At two hours post-treatment, pain freedom was achieved by 37% of participants with REN compared to 9% of the participants who took oral triptans and over the counter analgesic medications.
The device will be used to soothe episodic and chronic migraines among adolescents who are 12 years and older.
The researchers said while their work shows LGB Americans are at greater risk for migraines, they could not pinpoint the reasons why.
It is the first device of its kind considered safe for outpatient use.
If you suffer from migraines, you are basically stuck with three options, none of which are ideal.
About 40 million Americans suffer from migraines - intense headaches characterized by throbbing pain and sensitivity to light and nausea.
JPOST Digital Library
